Brown University

Transposon Therapeutics is at the forefront of developing therapies for neurodegenerative diseases, such as Alzheimer’s. The company’s cutting-edge genetic technologies emerged from research conducted at Brown University.

Phinyx AI is advancing artificial intelligence through its innovative Physics-Informed Machine Learning platform. Developed from research led by Dr. Georg Karniadakis, a Professor of Applied Mathematics and Engineering at Brown University, the technology integrates physical principles with machine learning to solve complex computational challenges.

Transposon Therapeutics employs 11 individuals and has raised more than $50 million in venture capital, reflecting its potential as a leader in neurodegenerative disease therapies.

Phinyx AI employs 5 individuals and makes notable advancements in the artificial intelligence field.

Brown University fosters a dynamic ecosystem for innovation and entrepreneurship, translating groundbreaking federally funded research into impactful companies and transformative technologies. The Nelson Center for Entrepreneurship provides teaching, mentorship and programming to support student entrepreneurship. Brown Technology Innovations supports Brown faculty members in developing new startup companies and industry research collaborations. This ecosystem enables the development of startups like Transposon Therapeutics and Phinyx AI, which are addressing pressing global challenges in biotechnology, artificial intelligence, and data  storage.